PIM
GSK icon

Perkins Investment Management’s GSK GSK Stock Holding History

Perkins Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-218,860
Closed -$12.6M – 263
2015
Q1 		$12.6M Buy
218,860
+19,680
+10% +$1.13M 0.13% 161
2014
Q4 		$10.6M Buy
199,180
+139,149
+232% +$7.78M 0.1% 187
2014
Q3 		$3.45M Sell
60,031
-81,396
-58% -$4.99M 0.03% 214
2014
Q2 		$9.45M Buy
141,427
+4,635
+3% +$314K 0.08% 177
2014
Q1 		$9.14M Buy
136,792
+49,152
+56% +$3.32M 0.07% 187
2013
Q4 		$5.85M Buy
87,640
+9,300
+12% +$603K 0.04% 200
2013
Q3 		$4.91M Sell
78,340
-32,900
-30% -$2.12M 0.03% 206
2013
Q2 		$6.95M Buy
+111,240
New +$7.06M 0.05% 212

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perkins Investment Management's GSK Position: Q2 2015 in Review

Perkins Investment Management sold out of GSK (GSK) in Q2 2015, closing a stake of 218,860 shares — an estimated $12.6M sold.

Perkins Investment Management first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $12.6M in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Perkins Investment Management reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Perkins Investment Management sold 218,860 GSK shares in Q2 2015, an estimated $12.6M.
  • Perkins Investment Management first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • Perkins Investment Management's GSK position peaked at $12.6M in Q1 2015.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Perkins Investment Management's 13F filing for Q2 2015, filed 17 Aug 2015.